BioCentury | Apr 22, 2019
Distillery Therapeutics
Combined inhibition of EGFR and RAF1 for mutant-KRAS, mutant TP53-driven PDAC
...M. et al. Cancer Cell ; published online Apr. 8, 2019 doi:10.1016/j.ccell.2019.03.002 CONTACT: Carmen Guerra, Spanish National Cancer Research Centre (CNIO)...
...CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish National Cancer Research Centre (CNIO) Epidermal...
...CONTACT: Mariano Barbacid, same affiliation as above email: mbarbacid@cnio.es Sandi Wong Ramon and Cajal Institute of Sanitary Research Spanish National Cancer Research Centre (CNIO) Epidermal...